Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
Clinical trial NCT04399395 · WITHDRAWN
Trial details
- NCT number
- NCT04399395
- Sponsor
- Oslo University Hospital
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2022-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.